Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124268812 | 12426881 | 2 | F | 201604 | 20160719 | 20160601 | 20160728 | PER | US-PFIZER INC-2016264371 | PFIZER | 55.00 | YR | F | Y | 136.80000 | KG | 20160728 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124268812 | 12426881 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 150 MG, 2X/DAY | Y | 20699 | 150 | MG | PROLONGED-RELEASE CAPSULE | BID | |||||
| 124268812 | 12426881 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Y | 20699 | PROLONGED-RELEASE CAPSULE | ||||||||||
| 124268812 | 12426881 | 3 | C | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | 400 MG, 2X/DAY | 0 | 400 | MG | CAPSULE | BID | ||||||
| 124268812 | 12426881 | 4 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 12.5 MG, 2X/DAY | 0 | 12.5 | MG | TABLET | BID | ||||||
| 124268812 | 12426881 | 5 | C | NEURONTIN | GABAPENTIN | 1 | Oral | 300 MG, 2X/DAY | 0 | 300 | MG | CAPSULE | BID | ||||||
| 124268812 | 12426881 | 6 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Oral | 50 MG, 1X/DAY | 0 | 50 | MG | TABLET | QD | ||||||
| 124268812 | 12426881 | 7 | C | METHADONE | METHADONE HYDROCHLORIDE | 1 | Oral | 10 MG, 2X/DAY | 0 | 10 | MG | TABLET | BID | ||||||
| 124268812 | 12426881 | 8 | C | VESICARE | SOLIFENACIN SUCCINATE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | ||||||
| 124268812 | 12426881 | 9 | C | PREVACID | LANSOPRAZOLE | 1 | Oral | 30 MG, DAILY | FM0787 | 0 | 30 | MG | CAPSULE | ||||||
| 124268812 | 12426881 | 10 | C | PREVACID | LANSOPRAZOLE | 1 | 0 | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124268812 | 12426881 | 1 | Bipolar disorder |
| 124268812 | 12426881 | 2 | Depression |
| 124268812 | 12426881 | 3 | Depression |
| 124268812 | 12426881 | 4 | Hypertension |
| 124268812 | 12426881 | 5 | Nerve injury |
| 124268812 | 12426881 | 6 | Pain |
| 124268812 | 12426881 | 7 | Back pain |
| 124268812 | 12426881 | 8 | Bladder disorder |
| 124268812 | 12426881 | 9 | Gastrooesophageal reflux disease |
| 124268812 | 12426881 | 10 | Dyspepsia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124268812 | 12426881 | Abnormal behaviour | |
| 124268812 | 12426881 | Anger | |
| 124268812 | 12426881 | Drug ineffective | |
| 124268812 | 12426881 | Fall | |
| 124268812 | 12426881 | Gait disturbance | |
| 124268812 | 12426881 | Insomnia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124268812 | 12426881 | 1 | 20160415 | 201605 | 0 |